Review
doi: 10.1053/j.seminhematol.2007.11.006.
The role of the immune system in myelodysplasia: implications for therapy
Affiliations
- PMID: 18179968
- DOI: 10.1053/j.seminhematol.2007.11.006
Item in Clipboard
Review
The role of the immune system in myelodysplasia: implications for therapy
Semin Hematol.
2008 Jan.
Abstract
Patients with myelodysplastic syndrome (MDS) have intrinsic, usually acquired genetic defects in their hematopoietic stem cells, but some others exhibit T-cell-mediated inhibition of hematopoiesis and good responses to immunosuppression. In these cases, MDS shares a similar pathophysiology with aplastic anemia (AA). Here, we review the evidence supporting a role of the immune system in the pathophysiology of MDS and the results of clinical trials of immunosuppressive agents.
Similar articles
-
Effects of cyclosporine on hematopoietic and immune functions in patients with hypoplastic myelodysplasia: in vitro and in vivo studies.Cancer. 2002 Nov 1;95(9):1911-22. doi: 10.1002/cncr.10915. Cancer. 2002. PMID: 12404285
-
[Immunosuppressive treatment of the myelodysplastic syndrome].Ugeskr Laeger. 2003 Jun 23;165(26):2654-7. Ugeskr Laeger. 2003. PMID: 12886548 Danish.
-
Determining which patients with myelodysplastic syndrome will respond to immunosuppressive treatment.Haematologica. 2006 May;91(5):583-4. Haematologica. 2006. PMID: 16670061 No abstract available.
-
Hypocellular myelodysplasia.Hematol Oncol Clin North Am. 2009 Apr;23(2):347-60. doi: 10.1016/j.hoc.2009.01.015. Hematol Oncol Clin North Am. 2009. PMID: 19327588 Review.
-
Immunosuppression for myelodysplastic syndrome: how bench to bedside to bench research led to success.Hematol Oncol Clin North Am. 2010 Apr;24(2):331-41. doi: 10.1016/j.hoc.2010.02.009. Hematol Oncol Clin North Am. 2010. PMID: 20359629 Free PMC article. Review.
Cited by
-
Myelodysplastic syndromes: an update on molecular pathology.Clin Transl Oncol. 2010 Oct;12(10):652-61. doi: 10.1007/s12094-010-0574-9. Clin Transl Oncol. 2010. PMID: 20947479 Review.
-
Toll-like receptor signaling in hematopoietic homeostasis and the pathogenesis of hematologic diseases.Front Med. 2015 Sep;9(3):288-303. doi: 10.1007/s11684-015-0412-0. Epub 2015 Aug 22. Front Med. 2015. PMID: 26297301 Review.
-
Predicting survival of patients with hypocellular myelodysplastic syndrome: development of a disease-specific prognostic score system.Cancer. 2012 Sep 15;118(18):4462-70. doi: 10.1002/cncr.27420. Epub 2012 Jan 17. Cancer. 2012. PMID: 22252728 Free PMC article.
-
Bone Marrow Immune Microenvironment in Myelodysplastic Syndromes.Cancers (Basel). 2022 Nov 17;14(22):5656. doi: 10.3390/cancers14225656. Cancers (Basel). 2022. PMID: 36428749 Free PMC article. Review.
-
Disordered Immune Regulation and its Therapeutic Targeting in Myelodysplastic Syndromes.Curr Hematol Malig Rep. 2018 Aug;13(4):244-255. doi: 10.1007/s11899-018-0463-9. Curr Hematol Malig Rep. 2018. PMID: 29934935 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
